{"id": "1383586199953035272", "creation": 1618707630.0, "user_id": "1211892441529241601", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 2, "reply_count": 0, "like_count": 8, "quote_count": 1}}, "text": "#China's first #mRNA #COVID19 #vaccine, ARCoV, will start Phase III clinical trial in May. Phase II trial jointly developed by Suzhou AbogenBio, Institute of Military Medicine under Academy of Military Sciences and Walvax Biotechnology, is running smoothly and drawing to a close. https://t.co/Mu8C4M88Ra", "first_save": 1634559108.199414, "hashtags": ["#CHINA", "#MRNA", "#COVID19", "#VACCINE"]}